By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


BTG plc 

10 Fleet Place
Limeburner Lane
London    EC4M 7SB  United Kingdom
Phone: 44-0-20-7575-0000 Fax: 44-0-20-7575-0010



Company News
BTG plc (BTG.L) Receives Health Canada Approval For DC Bead LUMI 8/25/2016 6:47:38 AM
BTG plc (BTG.L) Release: Varithena Earns FDA Approval For 30 Day Post-Activation Shelf Life 7/6/2016 9:26:40 AM
BTG plc (BTG.L) Release: New Study Highlights Potential Cost Savings When Using Yttrium-90 Glass Microspheres For Treatment Of Hepatocellular Carcinoma 5/27/2016 6:40:13 AM
BTG plc (BTG.L) Snaps Up Tumor Freezing Firm Galil Medical in $110 Million Deal 5/6/2016 5:53:22 AM
BTG plc (BTG.L) To Initiate Multi-Centre TARGET Study Evaluating Dosimetry For 90Y Radioembolisation Therapy In Patients With Hepatocellular Carcinoma 4/4/2016 6:04:06 AM
BTG plc (BTG.L) Announces US Launch Of LC Bead LUMI, Ground-Breaking Radiopaque Embolic Bead 4/1/2016 7:37:36 AM
BTG plc (BTG.L) Release: New Data From Largest Prospective Study On CroFab For Treatment Of Copperhead Snake Envenomation 3/9/2016 11:47:27 AM
BTG plc (BTG.L) Release: First Patient Treated With LC Bead LUMI Radiopaque Embolic Bead Supported By Royal Philips Electronics N.V. (PHG) Live Image Guidance 2/3/2016 6:12:04 AM
BTG plc (BTG.L) Release: First Patients In South Korea Receive TheraSphere Radioembolisation Treatment 1/27/2016 2:21:45 PM
BTG plc (BTG.L) Announces Presentation of New Vistogard (uridine triacetate) Data At ASCO Gastrointestinal Cancers Symposium (ASCO-GI) 1/20/2016 8:14:22 AM